Abstract
No abstract available.
🔖
Cite This Article
AKDAĞLI, A. E. (2020). May cyproheptadine be a treatment choice for prophylaxis of PFAPA syndrome?. The European Research Journal, Cilt: 6 - Sayı: 3, 268–269. https://ajindex.com/articles/360982
Journals / The European Research Journal / 2020 / Cilt: 6 - Sayı: 3
May cyproheptadine be a treatment choice for prophylaxis of PFAPA syndrome?
- Pages
- 268–269
- DOI
- —
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗References (5)
- Feder HM, Salazar JC. A clinical review of 105 patients with PFAPA (a periodic fever syndrome). Acta Paediatr 2010;99:178-84
- Thomas KT, Feder HM Jr, Lawton AR, Edwards KM. Periodic fever syndrome in children. J Pediatr 2013;135:15
- Stojanov S, Hoffmann F, Kéry A, Renner ED, Hartl D, Lohse P, et al. Cytokine profile in PFAPA syndrome suggests continuous inflammation and reduced anti-inflammatory response. Eur Cytokine Netw 2006;17:90-7
- Müller T, Dürk T, Blumenthal B, Grimm M, Cicko S, Panther E, et al. 5-hydroxytryptamine modulates migration, cytokine and chemokine release and T-cell priming capacity of dendritic cells in vitro and in vivo. PLoS One 2009;4:e6453
- Taniguchi K, Ono N, Sakai T, Ichiyama Y, Uemichi K. Response to cimetidine in a 1-year-old child with PFAPA syndrome. Turk J Pediatr 2016;58:687-9.